187 related articles for article (PubMed ID: 19686722)
1. The xenon-mediated antagonism against the NMDA receptor is non-selective for receptors containing either NR2A or NR2B subunits in the mouse amygdala.
Haseneder R; Kratzer S; Kochs E; Höfelmann D; Auberson Y; Eder M; Rammes G
Eur J Pharmacol; 2009 Oct; 619(1-3):33-7. PubMed ID: 19686722
[TBL] [Abstract][Full Text] [Related]
2. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
3. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.
Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G
Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096
[TBL] [Abstract][Full Text] [Related]
4. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
Fantin M; Marti M; Auberson YP; Morari M
J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
[TBL] [Abstract][Full Text] [Related]
5. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
Schotanus SM; Chergui K
Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
[TBL] [Abstract][Full Text] [Related]
6. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
7. Evidence that Xenon does not produce open channel blockade of the NMDA receptor.
Weigt HU; Adolph O; Georgieff M; Georgieff EM; Föhr KJ
J Neurophysiol; 2008 Apr; 99(4):1983-7. PubMed ID: 18234987
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
9. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
10. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn.
Haseneder R; Kratzer S; Kochs E; Mattusch C; Eder M; Rammes G
Anesthesiology; 2009 Dec; 111(6):1297-307. PubMed ID: 19934875
[TBL] [Abstract][Full Text] [Related]
11. Development and subunit composition of synaptic NMDA receptors in the amygdala: NR2B synapses in the adult central amygdala.
Lopez de Armentia M; Sah P
J Neurosci; 2003 Jul; 23(17):6876-83. PubMed ID: 12890782
[TBL] [Abstract][Full Text] [Related]
12. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
Kew JN; Trube G; Kemp JA
Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
[TBL] [Abstract][Full Text] [Related]
13. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
Schotanus SM; Chergui K
J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
15. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
16. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
Brimecombe JC; Potthoff WK; Aizenman E
J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
[TBL] [Abstract][Full Text] [Related]
17. Conditioning-strength dependent involvement of NMDA NR2B subtype receptor in the basolateral nucleus of amygdala in acquisition of auditory fear memory.
Zhang XH; Liu F; Chen Q; Zhang CL; Zhuo M; Xiong ZQ; Li BM
Neuropharmacology; 2008 Aug; 55(2):238-46. PubMed ID: 18573264
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
[TBL] [Abstract][Full Text] [Related]
20. Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons.
Thomas CG; Miller AJ; Westbrook GL
J Neurophysiol; 2006 Mar; 95(3):1727-34. PubMed ID: 16319212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
